In silico analysis using Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases revealed an association between a low expression of DUSP6 and a poor prognosis in NSCLC patients. This evidence concerns the gene DUSP6 and non-small cell lung carcinoma.